Skip to main content

Table 1 Demographic and clinical findings of the study patients

From: Predicting the outcome in confirmed COVID-19 patients with coronary artery disease: a key role for the first chest computed tomography

 

Total (n=48)

Age, mean

60.8±13.2

Male

36 (75)

Underlying cardiac disease

 

 History of CABG

24

 History of PCI

12

 History of positive coronary angiography/CT angiography

12

  Three vessel disease

1

  Two vessel disease

1

  Mild CAD*

10

 Concomitant valvular heart disease

5

Symptoms

 

 Chest pain

24 (50)

 Dyspnea

23 (47.9)

 Fever

12 (25)

 Coughing

12 (25)

 Muscle pain

4 (8.3)

 Fatigue

5 (10.4)

Symptom onset to chest CT

3 days

 Percentile 25th, 75th

1, 4 days

 Range

0–9 days

Risk factors and comorbidities

 

 Diabetes mellitus

22 (45.8)

 Hypertension

32 (66.7)

 cigarette smoking

16 (33.3)

 Dyslipidemia

23 (47.9)

 Opium addiction

8 (16.7)

 COPD

1 (2.1)

 Renal failure

5 (10.4)

 LVEF ≤35%

11 (22.9)

Drug history

 

 Insulin

6 (12.8)

 Oral DM drugs

7 (14.9)

 Statin

28 (60.9)

 ARB/ACEI

26 (54.2)

  1. CT, computed tomography; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; LVEF, left ventricular ejection fraction; ARB, angiotensin II receptor blocker; ACEI, angiotensin-converting-enzyme inhibitor
  2. *Mild coronary artery disease refers to 25–50% luminal stenosis in at least one of the major epicedial arteries